AIX Ventures

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026
Rounds participated in
2
Confirmed lead rounds
—
2 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$93.5M
2 disclosed · full round size, not this investor’s share

By stage

Seed1
Undisclosed1

By primary sector

AI1
Biotech1

By country

United States2

Rounds

2 in this selection
Unreasonable Labs

Builds an AI reasoning engine to generate scientific hypotheses across chemistry, materials science, and biology for industrial R&D

$13.5MSeed
Role not disclosed
Proxima

Develops AI-driven drug discovery for proximity therapeutics

$80MUndisclosed
Role not disclosed